Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario: Esperienza di un singolo centro

Translated title of the contribution: Concomitant adjuvant chemo-radiation therapy with anthracyclinebased regimens in breast cancer: A single centre experience

L. Livi, I. Meattini, V. Scotti, C. Saieva, G. Simontacchi, L. Marrazzo, C. Franzese, S. Cassani, F. Paiar, V. Di Cataldo, J. Nori, L. Jose Sanchez, S. Bianchi, L. Cataliotti, G. Biti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: This study was done to evaluate the toxicity related to concurrent radiotherapy and anthracycline (AC)-based chemotherapy in the adjuvant treatment of early breast cancer and to investigate the impact of treatment interruptions and the feasibility of this uncommon therapeutic approach. Materials and methods: From September 2002 to December 2007, 60 patients were treated at our Centre. The mean age at presentation was 48.5 (range 38-64) years. All patients underwent conservative surgery, and radiotherapy to the entire breast (mean dose 50 Gy; range 46-52 Gy). AC-based regimens consisted of four cycles of AC (doxorubicin plus cyclophosphamide) or four cycles of epirubicin (EPI) followed by four courses of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Results: Concomitant treatment caused acute skin G3 toxicity in 8.9% of patients and one case of G4 toxicity (1.7%). Concerning cardiac assessment, six of the 56 evaluable patients (10.7%) developed an asymptomatic decline of left ventricular ejection fraction >10% and

Original languageItalian
Pages (from-to)1050-1058
Number of pages9
JournalRadiologia Medica
Volume116
Issue number7
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Anthracyclines
Radiotherapy
Breast Neoplasms
Cyclophosphamide
Epirubicin
Therapeutics
Adjuvant Chemotherapy
Methotrexate
Fluorouracil
Stroke Volume
Doxorubicin
Breast
Skin

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario : Esperienza di un singolo centro. / Livi, L.; Meattini, I.; Scotti, V.; Saieva, C.; Simontacchi, G.; Marrazzo, L.; Franzese, C.; Cassani, S.; Paiar, F.; Di Cataldo, V.; Nori, J.; Jose Sanchez, L.; Bianchi, S.; Cataliotti, L.; Biti, G.

In: Radiologia Medica, Vol. 116, No. 7, 10.2011, p. 1050-1058.

Research output: Contribution to journalArticle

Livi, L, Meattini, I, Scotti, V, Saieva, C, Simontacchi, G, Marrazzo, L, Franzese, C, Cassani, S, Paiar, F, Di Cataldo, V, Nori, J, Jose Sanchez, L, Bianchi, S, Cataliotti, L & Biti, G 2011, 'Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario: Esperienza di un singolo centro', Radiologia Medica, vol. 116, no. 7, pp. 1050-1058. https://doi.org/10.1007/s11547-011-0652-2
Livi, L. ; Meattini, I. ; Scotti, V. ; Saieva, C. ; Simontacchi, G. ; Marrazzo, L. ; Franzese, C. ; Cassani, S. ; Paiar, F. ; Di Cataldo, V. ; Nori, J. ; Jose Sanchez, L. ; Bianchi, S. ; Cataliotti, L. ; Biti, G. / Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario : Esperienza di un singolo centro. In: Radiologia Medica. 2011 ; Vol. 116, No. 7. pp. 1050-1058.
@article{73507d33c2f54447abac9bba3aba38d3,
title = "Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario: Esperienza di un singolo centro",
abstract = "Purpose: This study was done to evaluate the toxicity related to concurrent radiotherapy and anthracycline (AC)-based chemotherapy in the adjuvant treatment of early breast cancer and to investigate the impact of treatment interruptions and the feasibility of this uncommon therapeutic approach. Materials and methods: From September 2002 to December 2007, 60 patients were treated at our Centre. The mean age at presentation was 48.5 (range 38-64) years. All patients underwent conservative surgery, and radiotherapy to the entire breast (mean dose 50 Gy; range 46-52 Gy). AC-based regimens consisted of four cycles of AC (doxorubicin plus cyclophosphamide) or four cycles of epirubicin (EPI) followed by four courses of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Results: Concomitant treatment caused acute skin G3 toxicity in 8.9{\%} of patients and one case of G4 toxicity (1.7{\%}). Concerning cardiac assessment, six of the 56 evaluable patients (10.7{\%}) developed an asymptomatic decline of left ventricular ejection fraction >10{\%} and",
keywords = "Adjuvant radiotherapy, Anthracyclines, Cardiac toxicity, Concomitant chemoradiotherapy, Early breast cancer",
author = "L. Livi and I. Meattini and V. Scotti and C. Saieva and G. Simontacchi and L. Marrazzo and C. Franzese and S. Cassani and F. Paiar and {Di Cataldo}, V. and J. Nori and {Jose Sanchez}, L. and S. Bianchi and L. Cataliotti and G. Biti",
year = "2011",
month = "10",
doi = "10.1007/s11547-011-0652-2",
language = "Italian",
volume = "116",
pages = "1050--1058",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "7",

}

TY - JOUR

T1 - Radio-chemioterapia concomitante con regimi a base di antracicline nel trattamento adiuvante del carcinoma mammario

T2 - Esperienza di un singolo centro

AU - Livi, L.

AU - Meattini, I.

AU - Scotti, V.

AU - Saieva, C.

AU - Simontacchi, G.

AU - Marrazzo, L.

AU - Franzese, C.

AU - Cassani, S.

AU - Paiar, F.

AU - Di Cataldo, V.

AU - Nori, J.

AU - Jose Sanchez, L.

AU - Bianchi, S.

AU - Cataliotti, L.

AU - Biti, G.

PY - 2011/10

Y1 - 2011/10

N2 - Purpose: This study was done to evaluate the toxicity related to concurrent radiotherapy and anthracycline (AC)-based chemotherapy in the adjuvant treatment of early breast cancer and to investigate the impact of treatment interruptions and the feasibility of this uncommon therapeutic approach. Materials and methods: From September 2002 to December 2007, 60 patients were treated at our Centre. The mean age at presentation was 48.5 (range 38-64) years. All patients underwent conservative surgery, and radiotherapy to the entire breast (mean dose 50 Gy; range 46-52 Gy). AC-based regimens consisted of four cycles of AC (doxorubicin plus cyclophosphamide) or four cycles of epirubicin (EPI) followed by four courses of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Results: Concomitant treatment caused acute skin G3 toxicity in 8.9% of patients and one case of G4 toxicity (1.7%). Concerning cardiac assessment, six of the 56 evaluable patients (10.7%) developed an asymptomatic decline of left ventricular ejection fraction >10% and

AB - Purpose: This study was done to evaluate the toxicity related to concurrent radiotherapy and anthracycline (AC)-based chemotherapy in the adjuvant treatment of early breast cancer and to investigate the impact of treatment interruptions and the feasibility of this uncommon therapeutic approach. Materials and methods: From September 2002 to December 2007, 60 patients were treated at our Centre. The mean age at presentation was 48.5 (range 38-64) years. All patients underwent conservative surgery, and radiotherapy to the entire breast (mean dose 50 Gy; range 46-52 Gy). AC-based regimens consisted of four cycles of AC (doxorubicin plus cyclophosphamide) or four cycles of epirubicin (EPI) followed by four courses of cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Results: Concomitant treatment caused acute skin G3 toxicity in 8.9% of patients and one case of G4 toxicity (1.7%). Concerning cardiac assessment, six of the 56 evaluable patients (10.7%) developed an asymptomatic decline of left ventricular ejection fraction >10% and

KW - Adjuvant radiotherapy

KW - Anthracyclines

KW - Cardiac toxicity

KW - Concomitant chemoradiotherapy

KW - Early breast cancer

UR - http://www.scopus.com/inward/record.url?scp=83655164489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655164489&partnerID=8YFLogxK

U2 - 10.1007/s11547-011-0652-2

DO - 10.1007/s11547-011-0652-2

M3 - Articolo

C2 - 21424317

AN - SCOPUS:83655164489

VL - 116

SP - 1050

EP - 1058

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 7

ER -